The new SunTech Oscar 2 24-hour ambulatory blood pressure monitoring system is now available with the True24 ABPM Patient Diary mobile app, which links to the Oscar 2 via Bluetooth. The True24 app provides a tutorial on ABPM, and prompts the patient to enter information about their activity, posture or any symptoms experienced during a physician-prescribed ABPM study. This diary information helps clinicians interpret the ambulatory blood pressure study data to make well-informed hypertension treatment decisions.


James Laskaris, emerging technology analyst at MD Buyline, recently offered his perspective on new medical technology innovations that might be just months or a few years away.



One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers that disappear and leave behind a bare metal stent. This engineering was created to solve ongoing issues in some patients whose vessels do not tolerate the antiproliferative drug-carrying polymers well, resulting in chronic inflammation. This can lead to late-stent thrombosis and is the basis for requiring long-term dual-antiplatelet therapy (DAPT).


Frost & Sullivan has released a new report, “Vision 2025 – Future of Healthcare,” part of the company’s Advanced Medical Technologies, that identifies 18 technologies that will impact healthcare paradigms by 2025.

January 16, 2017 — BioSig Technologies Inc. announced that the company’s Pure EP System, a novel cardiac electrophysiology (EP) signal acquisition and analysis system, was featured in the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology.


Each year imaging system manufacturers use the Radiological Society of North America (RSNA) meeting at the end of the year to unveil their latest technologies. RSNA 2016 included several new cardiovascular imaging advancements.

Watch the video “Editor's Choice of the Most Innovative New Technology at RSNA 2016” to see examples of some of the technologies discussed below. 

Speeding Cardiac MRI Workflow


January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the first in the U.S. to conduct a transcatheter mitral valve replacement using a device from Abbott called the Tendyne Bioprosthetic Mitral Valve. This was part of a study to learn if such a device could help patients with damaged mitral valves who were not good candidates for conventional surgery.

BioTrace Medical Inc. announced in December the first commercial use of the company’s Tempo Temporary Pacing Lead since U.S. Food and Drug Administration (FDA) 510(k) clearance in October 2016.

Subscribe Now